Literature DB >> 34125542

Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase.

Cien Huang1,2, Nina R Filippone1,3, Thomas Reiner1,4,5, Sheryl Roberts1.   

Abstract

Recruitment and activation of the ataxia telangiectasia mutated (ATM) kinase regulate multiple cell-cycle checkpoints relevant to complex biological events like DNA damage repair and apoptosis. Molecularly specific readouts of ATM using protein assays, fluorescence, or radiolabeling have advanced significantly over the past few years. This Review covers the molecular imaging techniques that enable the visualization of ATM-from traditional quantitative protein assays to the potential use of ATM inhibitors to generate new imaging agents to interrogate ATM. We are confident that molecular imaging coupled with advanced technologies will play a pivotal role in visualizing and understanding the biology of ATM and accelerate its applications in the diagnosis and monitoring of disease, including radiation therapy and patient stratification.

Entities:  

Keywords:  ATM inhibitors; ATM kinase; biosensors; molecular imaging

Mesh:

Substances:

Year:  2021        PMID: 34125542     DOI: 10.1021/acs.molpharmaceut.1c00166

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  2 in total

Review 1.  Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma.

Authors:  Liesbeth Everix; Shankari Nair; Cathryn H S Driver; Ingeborg Goethals; Mike M Sathekge; Thomas Ebenhan; Charlot Vandevoorde; Julie Bolcaen
Journal:  Cancers (Basel)       Date:  2022-04-03       Impact factor: 6.639

2.  Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent.

Authors:  Claudia Rose Fraser; Javier Ajenjo; Mathew Veal; Gemma Marie Dias; Chung Chan; Edward O'Neill; Gianluca Destro; Doreen Lau; Anna Pacelli; Veronique Gouverneur; Rebekka Hueting; Bart Cornelissen
Journal:  EJNMMI Res       Date:  2022-08-13       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.